Gad Soffer has been appointed chief operating officer of Cambridge, MA-based Rheos Medicines. Soffer most recently worked at Atara Biotherapeutics, where he was executive vice president and chief strategy officer. Before Atara, Soffer was executive director and global project leader at Celgene (NASDAQ: [[ticker:CELG]]). Rheos launched in March with a $60 million Series A round of funding to support its development of drugs that target cellular metabolism in order to treat disease.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
